The Phoenixville man who was convicted late last year of selling fentanyl-laced drugs under the trade name “Mega Millions” to ...

A Department of Justice (DOJ) court document reveals a lengthy rap sheet in the case of an alleged Hamas sympathizer ...

When New York State legalized recreational cannabis, officials did so with the promise to give those affected by the War on ...

As of March 31, 2025, the Company’s cash, cash equivalents and investments was $314.2 million. The Company expects that its cash, cash equivalents and investments, as of March 31, 2025, will fund its ...

"De-extinction" takes center stage as environmentalists express dismay over erosion of the Endangered Species Act ...

First Study to Confirm Safety of Stabilized Hyaluronic Acid (sHA) Rectal Spacer in Cases with Rectal Wall Infiltration (RWI).4 ...

Developed by Simple Promise, ElectroSlim is a lemon-lime flavored, sugar-free fizzy drink powder designed to assist in weight ...

As part of Xenon's ongoing collaboration with Neurocrine Biosciences, a Phase 1 study is underway of NBI-921355, an investigational, selective inhibitor of voltage-gated sodium channels Nav1.2 and ...

Ascendis Pharma A/S (Nasdaq: ASND) today announced new data from Week 214 of its Phase 2 PaTH Forward Trial showing that long-term treatment with TransCon PTH (palopegteriparatide) continued to ...

After over a decade of one-party rule and a mass exodus from the “Golden State,” Republican gubernatorial candidate and ...

The clinical, cardiovascular and neuroendocrine profile of ampreloxetine showed target engagement of residual peripheral autonomic neurons and a sustained standing blood pressure effect, which is ...